Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Bariatric surgery, including procedures like gastric bypass or sleeve gastrectomy, involves a significant intervention altering your digestive system
Key Takeaways AOD 9604 produces 2-3 times greater fat loss than placebo in clinical trials with women Standard dosing ranges from 0.5mg to 1mg daily via subcutaneous injection Side effects occur in fewer than 5% of women, primarily mild injection site reactions Results typically become visible after 4-6 weeks of consistent daily administration The peptide preserves lean muscle mass while specifically targeting fat tissue How AOD 9604 Works for Female Fat Loss AOD 9604 functions by activating beta-3 adrenergic receptors in adipose tissue, specifically triggering lipolysis without the growth-promoting effects of full-length growth hormone
retail pharmacies reached 2.6 million by Dec 2023 ( [1] ), and global sales of GLP-1 therapies topped $54 billion in 2024 ( [2] )
Last Update: 18 May 2019
Kirkham, T
